2seventy bio, Inc.
TSVT
$3.10
$0.4516.98%
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | -10.25% | 167.38% | 393.78% | 250.36% | -30.37% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -10.25% | 167.38% | 393.78% | 250.36% | -30.37% |
| Cost of Revenue | -9.40% | -11.76% | -3.42% | 7.82% | 1.08% |
| Gross Profit | 9.17% | 52.28% | 53.63% | 80.74% | -15.44% |
| SG&A Expenses | -33.69% | 12.80% | -13.16% | -23.61% | -14.72% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -15.23% | -7.07% | -5.77% | -1.29% | -3.22% |
| Operating Income | 16.21% | 37.65% | 42.96% | 60.29% | -4.80% |
| Income Before Tax | -5.54% | 45.64% | 45.14% | 62.02% | -13.13% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.54% | 45.64% | 45.14% | 62.05% | -13.13% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.54% | 45.64% | 45.14% | 62.05% | -13.13% |
| EBIT | 16.21% | 37.65% | 42.96% | 60.29% | -4.80% |
| EBITDA | 17.38% | 37.90% | 43.24% | 61.71% | -8.95% |
| EPS Basic | 20.46% | 59.06% | 66.24% | 76.56% | 31.46% |
| Normalized Basic EPS | 43.42% | 59.07% | 66.27% | 76.61% | 31.46% |
| EPS Diluted | 20.46% | 59.06% | 66.24% | 76.56% | 31.46% |
| Normalized Diluted EPS | 43.42% | 59.07% | 66.27% | 76.61% | 31.46% |
| Average Basic Shares Outstanding | 32.68% | 32.79% | 62.49% | 61.95% | 65.06% |
| Average Diluted Shares Outstanding | 32.68% | 32.79% | 62.49% | 61.95% | 65.06% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
